News

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

In experiments in mice, Johns Hopkins Medicine researchers have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

Researchers have found a way to repurpose cells more reliably than current methods by untangling DNA, clearing a roadblock in regenerative medicine to reach treatments for a wide range of diseases.

Researchers have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.

In a mouse model of stroke, researchers successfully pioneer a new gene therapy developed to turn glial cells into neurons.

Current medications for malaria are becoming less effective as drug resistance spreads, but the frigid waters of the Antarctic may yield a treatment.

In a world first, researchers from Penn Medicine have used genetically modified T cells to target and ablate fibroblasts that contribute to the development of heart disease.

To understand the influence of aging on the effectiveness of immune checkpoint blockade (ICB) therapy, researchers conducted preclinical studies using younger and older mice with triple negative breast cancer, finding that age affects the efficacy of ICB therapy.

Oral antibiotics, which can kill gut microorganisms, can alter the human immune response to seasonal influenza vaccination.